News & Updates
Filter by Specialty:
Tezepelumab improves lung function in severe asthma
In the treatment of patients with severe, uncontrolled asthma, use of tezepelumab appears to produce rapid and sustained improvements in lung function, as reported in a study.
Tezepelumab improves lung function in severe asthma
19 Oct 2021
3-day remdesivir prevents hospitalization, death in COVID-19
A 3-day course of remdesivir may help stave off COVID-19–related hospitalization and death, according to results of the phase III PINETREE study.
3-day remdesivir prevents hospitalization, death in COVID-19
18 Oct 2021
Antiplatelet plus anticoagulant therapy linked to better outcomes in COVID-19
Hospitalized patients with COVID-19 who receive antiplatelet and anticoagulant drugs concurrently may fare better than those given only therapeutic anticoagulation, according to a study.
Antiplatelet plus anticoagulant therapy linked to better outcomes in COVID-19
18 Oct 2021
Proteomic profiling of COPD may lead to new treatment strategies
A recent study has provided a detailed proteomic profile that identified proteins associated with the pathogenesis and disease progression of chronic obstructive pulmonary disease (COPD), which can then help in the creation of platform to develop effective new treatment strategies.
Proteomic profiling of COPD may lead to new treatment strategies
17 Oct 2021
One in 10 Singaporeans affected by asthma
A recent multi-ethnic Singapore study confirms that asthma is a common disease, affecting more than 10 percent of adults, especially former smokers and those with high body mass index (BMI). Asthma is also associated with worse health-related quality of life (HRQoL), making it a substantial public health concern.
One in 10 Singaporeans affected by asthma
15 Oct 2021
Lenzilumab reduces likelihood of survival without ventilation in COVID-19 patients
In hospitalized COVID-19 patients, treatment with the novel GM-CSF* neutralizing monoclonal antibody lenzilumab led to a significant improvement in survival without invasive mechanical ventilation (SWOV), findings from the phase III LIVE-AIR study suggest.
